By using the model, you agree to the terms and conditions.
Reference: Erik van Werkhoven, Guus Hart, Harm van Tinteren, et al. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881–10882 boost versus no boost trial. Radiotherapy and Oncology, 100 (2011), pp. 101–107 (free access).
Copyright (c) 2012, NKI/AvL
All rights reserved.